All articles by Juliet Martin

Laboratory services poised for the digital revolution

The clinical trials landscape is evolving more rapidly than ever before. The COVID-19 pandemic and geopolitical instability have put new…
Accessible, interactive, reliable: the next generation in participant consent

A clinical trial can’t begin without first obtaining patient consent. Sponsors are responsible for ensuring that all participants understand the…
How improved plain language summaries can boost your CT patient engagement

The World Health Organisation (WHO) reports that “patient engagement is increasingly recognised as an integral part of healthcare”. At a…
Using analytics and bioassays to de-risk your mRNA LNP drug development programme

The swift development and deployment of messenger-RNA (mRNA) vaccines against the SARS-CoV-2 virus during the COVID-19 crisis has catapulted the…
Business ecosystems in asset finance: Greater than the sum of their parts

The once cut-throat business landscape is evolving, and business ecosystems are on the rise. Open APIs are facilitating unprecedented collaboration,…

New EU-CTR and what it means for Part I clinical trial documentation

In January 2022, the new EU Clinical Trials Regulation (EU-CTR) was introduced, giving clinical trial sponsors a three-year window to…
The supply chain innovations behind the world’s largest vaccine programme

In 2020, the pharmaceutical supply chain faced one of its biggest global challenges. The COVID-19 pandemic pushed manufacturers, distributors, governments…
Rising demand for pediatric dosage forms requires reformulation, expertise, and to-scale manufacturing capabilities

Pharmaceutical companies are looking to paediatric indications of approved adult dosage forms (ADFs) to sustain and fuel growth. The desire…
War in Ukraine: What it means for clinical trial operations

Russia’s full-scale invasion of Ukraine in February has had local, regional and global ramifications for clinical trial operations. Alongside its…
Lay of the land: Understanding lay summary requirements and the challenges they bring

The pharmaceutical industry has undergone a significant shift towards patient-centred services with an emphasis on transparency in recent years. A…